Novel Social Media Intervention For Older Br CA Patients
|ClinicalTrials.gov Identifier: NCT02639208|
Recruitment Status : Active, not recruiting
First Posted : December 24, 2015
Last Update Posted : July 5, 2019
The number of patients 60 and older with breast cancer is increasing as our population ages. Despite the fact that the majority of breast cancers occur in patients 60 and over, these patients are consistently under-represented in clinical trials. Because patients 60 and older are an under-studied group, investigators do not have detailed information on the side effects and experiences for these patients receiving chemotherapy. Understanding the side effects patients receiving chemotherapy experience is an important part of this study.
In addition, past research has shown that having poor social support can affect quality of life, mood, and outcomes for people with cancer. However, few studies in the past have focused on improving the quality of life and support systems that patients have while they receive treatment.
This research study is evaluating how engaging in an online support community may improve the experience of older patients receiving chemotherapy.
|Condition or disease||Intervention/treatment||Phase|
|Breast Cancer Stage I Breast Cancer Stage II Breast Cancer Stage III||Other: PatientsLikeMe (PLM)||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||47 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Supportive Care|
|Official Title:||Improving Support for Older Patients Receiving Neo/Adjuvant Chemotherapy for Breast Cancer Using a Novel Social Media Intervention|
|Study Start Date :||December 2015|
|Actual Primary Completion Date :||May 2019|
|Estimated Study Completion Date :||December 2020|
Experimental: PatientsLikeMe (PLM)
After the screening procedures confirm eligibility.
Other: PatientsLikeMe (PLM)
- Feasibility/ Rate of Participant Login - PLM [ Time Frame: 4-6 months ]We will describe the degree of patient use of the PLM platforms and the associations of short and longer term PLM use with patient characteristics
- Rate of Usability of PLM [ Time Frame: 6 Months ]Usability (how useful they found PLM, what parts of the site they used, etc.) will be assessed using a patient experience survey at the end of the study
- Rate of Overall Satisfaction with PLM [ Time Frame: 6 Months ]Satisfaction with the PLM experience wil be assessed using a 'patient experience' survey at the end of the study
- Rate of Desirability with PLM [ Time Frame: 6 Months ]Desirability (how much they enjoyed using PLM, etc) wil be assessed using a patient experience survey at the end of the study
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02639208
|United States, Massachusetts|
|Dana-Farber Cancer Institute|
|Boston, Massachusetts, United States, 02115|
|Principal Investigator:||Rachel Freedman, MD||Dana-Farber Cancer Institute|